Similar Posts
Science Isn’t Meant To Be Followed
Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.
Pandemics and Overdoses: COVID-19 May Worsen Our Opioid Epidemic
The novel coronavirus has decimated our economy at the same time as it has directly threatened our health. As if that weren’t bad enough, the economic damage Covid-19 is causing could have an indirect impact on our health. Consider what we already know about economic downturns and opioid overdoses. A research team led by Atheendar…
Preventing Diabetes – What Medicare Administrators Could Learn From Shark Tank
The Medicare Diabetes Prevention Program is a lifesaver. Consisting of of at least 16 class sessions that provide practical training about healthy eating, physical activity, and other strategies for weight control, the Program reduces the chance that people at high risk for diabetes actually develop that life-threatening condition.
However, the Program is floundering, with distressingly few people having access to or enrolling in the program. Could it be because Medicare administrators haven’t watched enough episodes of Shark Tank?
Buying Junk Food With Taxpayer Dollars: Whether Interventions to Encourage Healthy Purchasing Work
One of my elderly relatives was in line at the grocery store one day and saw the person ahead of him charging what looked like a cart full of junk food to her food assistance card. My relative was incensed: Why, should his hard earned tax dollars be used to pay for someone’s Cheetos? Currently,…
Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
Expert: NC better positioned than other states to respond to pandemic (WRAL)
The slow growth in coronavirus cases in North Carolina relative to New York and some other states puts North Carolina in better position to respond to the pandemic, according to a Duke University professor. Economist Mark McClellan, the director of the Duke-Margolis Center for Health Policy, was U.S. Food and Drug Administration commissioner during the…
